|제목||PharmAbcine, non-confidential slide deck Q4 2021|
Notice of Changes:
1. The introduction slides on company overview, core technologies, and main pipelines have been modified
2. The company’s long-term growth strategy slide has been added
3. Olinvacimab’s phase 2 mTNBC (metastatic Triple-Negative Breast Cancer) clinical design slide has been added
4. A market potential slide of PMC-403 in ophthalmology has been added
5. A slide on the PMC-309’s strengths in the current immuno-oncology market has been added
Please check the attached file for details.
Thank you for your continued support.